Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADVANCED MICRO DEVICES INCAMD · Entity 2796 | SVP, GC & Corporate Secretary | August 18, 2026 | August 20, 2026 |
| LAM RESEARCH CORPLRCX · Entity 1467 | Chief Legal Officer & SVP | January 03, 2024 | January 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADVANCED MICRO DEVICES INC
Report date August 18, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,623 |
Reported balance
After 2026-08-18 transaction · row 1
1 source rowRow 1 · 2026-08-18 · Sale · Disposed 2,993 · Balance 26,623 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
LAM RESEARCH CORP
Report date January 03, 2024 · Filed January 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,433 |
Last balance in matching sequence
After 2024-01-03 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-01-03 · Exercise / conversion · Acquired 2,342 · Balance 5,775 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. F2: The amount reported includes shares subject to unvested restricted stock units. Row 2 · 2024-01-03 · Sale · Disposed 2,342 · Balance 3,433 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. F2: The amount reported includes shares subject to unvested restricted stock units. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $300.33 · Expires 2027-03-02 | Direct | 0 |
Reported balance
After 2024-01-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-01-03 · Exercise / conversion · Disposed 2,342 · Balance 0 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023. F3: The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023.
F2: The amount reported includes shares subject to unvested restricted stock units.
F3: The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CA, INC.
Report date November 05, 2018 · Filed November 05, 2018
Section 16 reporting ended · disclosed 2018-11-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.10 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-05 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-11-05 · Disposition to issuer · Disposed 11,337 · Balance 0 F1: This restricted stock award ("RSA") provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. In connection with that certain Agreement and Plan of Merger between the Issuer, Broadcom Inc. ("Broadcom") and Collie Acquisition Corp., dated as of July 11, 2018 (the "Merger Agreement") and pursuant to a letter agreement between the Issuer, Broadcom and the Reporting Person (the "Letter Agreement"), immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Merger"), all unvested Issuer RSAs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSA, less applicable tax withholdings. |
| Common Stock, $.10 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-05 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2018-11-05 · Disposition to issuer · Disposed 30,056 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. The RSUs provided for vesting over three years as follows: 34% on February 15, 2019, 33% on February 15, 2020, and 33% on February 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of the Merger, all unvested Issuer RSUs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSU, less applicable tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.28 · Expires 2028-05-15 | Direct | 0 |
Reported balance
After 2018-11-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-05 · Disposition to issuer · Disposed 70,294 · Balance 0 F3: This option provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of Merger, all unvested options held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such unvested option, less the aggregate exercise price corresponding to such Issuer option and less applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: This restricted stock award ("RSA") provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. In connection with that certain Agreement and Plan of Merger between the Issuer, Broadcom Inc. ("Broadcom") and Collie Acquisition Corp., dated as of July 11, 2018 (the "Merger Agreement") and pursuant to a letter agreement between the Issuer, Broadcom and the Reporting Person (the "Letter Agreement"), immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Merger"), all unvested Issuer RSAs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSA, less applicable tax withholdings.
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. The RSUs provided for vesting over three years as follows: 34% on February 15, 2019, 33% on February 15, 2020, and 33% on February 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of the Merger, all unvested Issuer RSUs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSU, less applicable tax withholdings.
F3: This option provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of Merger, all unvested options held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such unvested option, less the aggregate exercise price corresponding to such Issuer option and less applicable tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 22:12 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 2,172 | $0.00 Strike: $490.92 | $0.00 |
DisclosureSEC source: 0000707549-23-000072 · wf-form4_167788149251852.xml · derivative · entry 9 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,172 Underlying: Common Stock · 2,172 shares Expires 2030-03-01 F6 · derivative.exercise_date: The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:12 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 2,654 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000072 · wf-form4_167788149251852.xml · derivative · entry 8 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,654 Underlying: Common Stock · 2,654 shares Expires not disclosed F5 · derivative.exercise_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026. F5 · derivative.expiration_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:12 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 131 | $490.92 | $64,310.52 |
DisclosureSEC source: 0000707549-23-000072 · wf-form4_167788149251852.xml · nonDerivative · entry 3 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,151 F3 · shares: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:12 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 125 | $490.92 | $61,365.00 |
DisclosureSEC source: 0000707549-23-000072 · wf-form4_167788149251852.xml · nonDerivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,282 F3 · shares: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:12 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 1,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000072 · wf-form4_167788149251852.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,407 F1 · shares: The restricted stock units will vest in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 23:41 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionMarket-based Performance Restricted Stock Unit · Derivative | 4,393 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000021 · wf-form4_167598609867058.xml · derivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Market-Based Performance Restricted Stock Units will vest between 0% and 150% on 03/02/2023. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from February 3, 2020, to February 2, 2023. F3 · derivative.expiration_date: The Market-Based Performance Restricted Stock Units will vest between 0% and 150% on 03/02/2023. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from February 3, 2020, to February 2, 2023. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 23:41 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 5,059 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000021 · wf-form4_167598609867058.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On 03/02/2020, the Reporting Person received a target grant of 4,393 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/02/2023. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from February 3, 2020, to February 2, 2023. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 549 | $554.02 | $304,156.98 |
DisclosureSEC source: 0000707549-22-000038 · wf-form4_164634291917739.xml · nonDerivative · entry 3 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 F3 · shares: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,710 | $0.00 Strike: $540.57 | $0.00 |
DisclosureSEC source: 0000707549-22-000038 · wf-form4_164634291917739.xml · derivative · entry 5 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,710 Underlying: Common Stock · 1,710 shares Expires 2029-03-01 F5 · derivative.exercise_date: The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 2,090 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-22-000038 · wf-form4_164634291917739.xml · derivative · entry 4 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,090 Underlying: Common Stock · 2,090 shares Expires not disclosed F4 · derivative.exercise_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025. F4 · derivative.expiration_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 125 | $540.57 | $67,571.25 |
DisclosureSEC source: 0000707549-22-000038 · wf-form4_164634291917739.xml · nonDerivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449 F3 · shares: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 1,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-22-000038 · wf-form4_164634291917739.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,574 F1 · shares: The restricted stock units will vest in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 721 | $570.75 | $411,510.75 |
DisclosureSEC source: 0000707549-21-000067 · wf-form4_161488740025021.xml · nonDerivative · entry 4 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,434 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,170 | $0.00 Strike: $300.33 | $0.00 |
DisclosureSEC source: 0000707549-21-000067 · wf-form4_161488740025021.xml · derivative · entry 5 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,342 Underlying: Common Stock · 1,170 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F4 · derivative.exercise_date: The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 450 | $573.36 | $258,012.00 |
DisclosureSEC source: 0000707549-21-000067 · wf-form4_161488740025021.xml · nonDerivative · entry 3 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,155 F3 · shares: Represents shares that were automatically withheld upon vesting of restricted stock units to satisfy tax withholding obligations. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 1,170 | $594.01 | $694,991.70 |
DisclosureSEC source: 0000707549-21-000067 · wf-form4_161488740025021.xml · nonDerivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,605 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 19:50 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 1,170 | $300.33 | $351,386.10 |
DisclosureSEC source: 0000707549-21-000067 · wf-form4_161488740025021.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:20 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantStock Option (right to buy) · Derivative | 816 | $0.00 Strike: $598.81 | $0.00 |
DisclosureSEC source: 0000707549-21-000049 · wf-form4_161478839802176.xml · derivative · entry 3 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816 Underlying: Common Stock · 816 shares Expires 2028-03-01 F4 · derivative.exercise_date: The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:20 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 1,363 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-21-000049 · wf-form4_161478839802176.xml · derivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,363 Underlying: Common Stock · 1,363 shares Expires not disclosed F3 · derivative.exercise_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2024. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2021 through 01/31/2024. F3 · derivative.expiration_date: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2024. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2021 through 01/31/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:20 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 1,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-21-000049 · wf-form4_161478839802176.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,605 F1 · shares: The restricted stock units will vest in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:14 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,512 | $300.33 Strike: $300.33 | $1,054,758.96 |
DisclosureSEC source: 0000707549-20-000052 · wf-form4_158327364184964.xml · derivative · entry 3 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,512 Underlying: Common Stock · 3,512 shares Expires 2027-03-02 F4 · derivative.exercise_date: The stock option becomes exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:14 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 4,393 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000707549-20-000052 · wf-form4_158327364184964.xml · derivative · entry 2 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,393 Underlying: Common Stock · 4,393 shares Expires not disclosed F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 03/02/2023. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 02/03/2020 through 02/02/2023. F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 03/02/2023. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 02/03/2020 through 02/02/2023. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:14 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 3,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-20-000052 · wf-form4_158327364184964.xml · nonDerivative · entry 1 Hahn Ava · CIK 0001267376 · Chief Legal Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515 F1 · shares: The Restricted Stock Units will vest in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 05, 2018 Filed Nov 5, 2018 20:16 UTC | CA, INC. CA · Entity 162566 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 70,294 | $0.00 Strike: $35.28 | $0.00 |
DisclosureSEC source: 0000899243-18-028249 · doc4.xml · derivative · entry 3 HAHN AVA · CIK 0001267376 · EVP GC, Corp Sec & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.10 par value · 70,294 shares Expires 2028-05-15 F3 · derivative.exercise_date: This option provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of Merger, all unvested options held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such unvested option, less the aggregate exercise price corresponding to such Issuer option and less applicable tax withholdings. Read SEC document |
| November 05, 2018 Filed Nov 5, 2018 20:16 UTC | CA, INC. CA · Entity 162566 | Disposition to issuerCommon Stock, $.10 par value | 30,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-028249 · doc4.xml · nonDerivative · entry 2 HAHN AVA · CIK 0001267376 · EVP GC, Corp Sec & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. The RSUs provided for vesting over three years as follows: 34% on February 15, 2019, 33% on February 15, 2020, and 33% on February 15, 2021. Pursuant to the Letter Agreement, immediately prior to the effective time of the Merger, all unvested Issuer RSUs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSU, less applicable tax withholdings. Read SEC document |
| November 05, 2018 Filed Nov 5, 2018 20:16 UTC | CA, INC. CA · Entity 162566 | Disposition to issuerCommon Stock, $.10 par value | 11,337 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-028249 · doc4.xml · nonDerivative · entry 1 HAHN AVA · CIK 0001267376 · EVP GC, Corp Sec & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This restricted stock award ("RSA") provided for vesting over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. In connection with that certain Agreement and Plan of Merger between the Issuer, Broadcom Inc. ("Broadcom") and Collie Acquisition Corp., dated as of July 11, 2018 (the "Merger Agreement") and pursuant to a letter agreement between the Issuer, Broadcom and the Reporting Person (the "Letter Agreement"), immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Merger"), all unvested Issuer RSAs held by the Reporting Person were converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock covered by such RSA, less applicable tax withholdings. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:40 UTC | CA, INC. CA · Entity 162566 | GrantEmployee Stock Option (right to buy) · Derivative | 70,294 | $0.00 Strike: $35.28 | $0.00 |
DisclosureSEC source: 0000356028-18-000076 · wf-form4_152660400408771.xml · derivative · entry 2 HAHN AVA · CIK 0001267376 · EVP GC, Corp Sec & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,294 Underlying: Common Stock, $.10 par value · 70,294 shares Expires 2028-05-15 F2 · derivative.exercise_date: The option becomes exercisable over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:40 UTC | CA, INC. CA · Entity 162566 | GrantCommon Stock, $.10 par value | 11,337 | $0.00 | $0.00 |
DisclosureSEC source: 0000356028-18-000076 · wf-form4_152660400408771.xml · nonDerivative · entry 1 HAHN AVA · CIK 0001267376 · EVP GC, Corp Sec & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,393 F1 · shares: Represents restricted stock which, subject to earlier forfeiture, vests over three years as follows: 34% on May 15, 2019, 33% on May 15, 2020 and 33% on May 15, 2021. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 17:38 UTC | CA, INC. CA · Entity 162566 | GrantCommon Stock, $.10 par value | 30,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000356028-18-000035 · wf-form4_151882069686627.xml · nonDerivative · entry 1 HAHN AVA · CIK 0001267376 · EVP General Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,056 F1 · shares: Represents restricted stock units which vest as follows: 34% on February 15, 2019, 33% on February 15, 2020, and 33% on February 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.